- Home
- Research
Research areas
The Center addresses complex policy considerations by leveraging collective scientific experience across a range of disciplines. Our mission is to lead robust scientific research to support the development of evidence-based policies that accelerate medical innovation and enhance patient value, access and affordability.
Value
Respect for individual patient needs should be at the heart of evaluating medical innovation. We study and develop patient-centered and clinically-driven approaches to value assessment.
The objective: Ensure that methods and approaches to valuing pharmaceuticals reflect the holistic value to patients, as well as broader benefits to the healthcare system and society.
Access
Patients in the U.S. benefit from the earliest access to the most advanced treatments. Our research examines the systems and policies that govern how patients access medicines and receive appropriate treatment.
The objective: Enhance patient affordability and access to high-value therapies so that everyone can achieve their full potential and live healthier, more fulfilling lives.
Innovation
The U.S. leads the world with the most robust medical research and development ecosystem, uniquely combining public and private-sector contributions. We research policies that support and strengthen the nation’s leadership role in research, development and manufacturing.
The objective: Demonstrate the importance of accelerating medical innovation to achieve greater advancements in human health.
Our research goals
The Center advances healthcare policy through research, analysis and public engagement. Our focus includes:
- Developing original research to inform policy decisions.
- Publishing articles, issue briefs, policy perspectives and insights backed by data and analysis.
- Conducting policy analysis and providing timely responses to a rapidly evolving landscape.
Our research
Read the Center’s latest research and analyses.
How does non-medical switching affect patient outcomes?
A systematic review highlights its negative consequences
Understanding state Medicaid spending on prescription drugs
This analysis demonstrates that state Medicaid programs are estimated to be spending near or below the national average on prescription drugs.